Qurient Co., Ltd. Logo

Qurient Co., Ltd.

Biopharma developing novel drugs for cancer, inflammation, and infectious diseases.

115180 | KO

Overview

Corporate Details

ISIN(s):
KR7115180002
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 판교로 242, C동 8층, 성남시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Qurient Co., Ltd. is a clinical-stage biopharmaceutical company established in 2008, focused on the research and development of novel therapeutics for unmet medical needs. The company operates on a unique "Network R&D" model, a virtual project management system that integrates external research and drug development capabilities to advance its pipeline from early discovery to clinical proof-of-concept. Its portfolio consists of small molecule drug candidates targeting indications in oncology, inflammation, and infectious diseases, with the mission of providing innovative treatments to patients globally.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-29 00:00
Share Issue/Capital Change
주요사항보고서(신주인수권부사채권발행결정)
Korean 88.4 KB
2025-10-29 00:00
Capital/Financing Update
주요사항보고서(전환사채권발행결정)
Korean 107.1 KB
2025-10-21 00:00
Share Issue/Capital Change
전환주식의전환청구권행사
Korean 14.6 KB
2025-10-17 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-09-25 00:00
Regulatory News Service
투자판단관련주요경영사항 (이중 페이로드 항체약물 접합체(ADC) 개발을 위한 플랫폼 기술 도입 계약 체결)
Korean 10.0 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-07-29 00:00
Legal Proceedings Report
투자판단관련주요경영사항(임상시험계획승인신청) (만성 이식편대숙주질환 환자 대상 Q702 단독치료요법의 유럽 임상 제1b…
Korean 10.8 KB
2025-07-17 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.2 KB
2025-06-19 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 66.5 KB
2025-05-28 00:00
Share Issue/Capital Change
전환주식의전환청구권행사
Korean 14.4 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.5 MB
2025-04-23 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.0 KB
2025-04-17 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 98.8 KB
2025-04-17 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-04-17 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 129.3 KB

Automate Your Workflow. Get a real-time feed of all Qurient Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Qurient Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Qurient Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CIZZLE BIOTECHNOLOGY HOLDINGS PLC Logo
Developing a CIZ1B biomarker blood test for the early detection of lung cancer.
United Kingdom
CIZ
Clear Channel Outdoor Holdings, Inc. Logo
An OOH ad platform connecting brands to consumers via digital billboards and data analytics.
United States of America
CCO
CODEXIS, INC. Logo
Engineering high-performance enzymes for pharma, diagnostics, and life science manufacturing.
United States of America
CDXS
Cogent Biosciences, Inc. Logo
Developing precision small molecule therapies for cancers, autoimmune, and rare diseases.
United States of America
COGT
COMPASS Pathways plc Logo
Developing psilocybin therapies for severe mental health challenges like TRD and PTSD.
United States of America
CMPS
COMSCORE, INC. Logo
Cross-platform audience measurement and media analytics for advertisers, publishers, and agencies.
United States of America
SCOR
COPRO-HOLDINGS. Co., Ltd. Logo
Dispatches technical personnel to Japan's construction & plant industries.
Japan
7059
Corbus Pharmaceuticals Holdings, Inc. Logo
Clinical-stage oncology company developing targeted therapies like ADCs for cancer and obesity.
United States of America
CRBP
Corvus Pharmaceuticals, Inc. Logo
Develops novel, targeted therapies for immune diseases and cancer.
United States of America
CRVS
Coya Therapeutics, Inc. Logo
Developing Treg-modulating therapies for neurodegenerative and autoimmune diseases.
United States of America
COYA

Talk to a Data Expert

Have a question? We'll get back to you promptly.